Matches in Nanopublications for { ?s ?p "[Our results demonstrate that YK-4-279 is a potent inhibitor of ETV1 and inhibits both the primary tumor growth and metastasis of fusion positive prostate cancer xenografts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- assertion description "[Our results demonstrate that YK-4-279 is a potent inhibitor of ETV1 and inhibits both the primary tumor growth and metastasis of fusion positive prostate cancer xenografts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Our results demonstrate that YK-4-279 is a potent inhibitor of ETV1 and inhibits both the primary tumor growth and metastasis of fusion positive prostate cancer xenografts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1245186.RAryLSm5m0IqNBrBUgSEHMmAFIO72hwotzq0l3kU4mTyU130_assertion description "[Our results demonstrate that YK-4-279 is a potent inhibitor of ETV1 and inhibits both the primary tumor growth and metastasis of fusion positive prostate cancer xenografts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1245186.RAryLSm5m0IqNBrBUgSEHMmAFIO72hwotzq0l3kU4mTyU130_provenance.
- NP1245184.RAHtNBtrnsgd5-JY4EKsVMaREhyVEXuq6l6XuYJZKumFg130_assertion description "[Our results demonstrate that YK-4-279 is a potent inhibitor of ETV1 and inhibits both the primary tumor growth and metastasis of fusion positive prostate cancer xenografts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1245184.RAHtNBtrnsgd5-JY4EKsVMaREhyVEXuq6l6XuYJZKumFg130_provenance.